Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Trump:"The cost of medicine in this country is outrageous"
View:
Post by GenericAdvocate on Mar 21, 2017 12:38am

Trump:"The cost of medicine in this country is outrageous"

Trump says GOP is adding drug price reform to bill. "If we can't, we'll add it later…we have some crazy, arcane laws, if you haven't heard."

 
Comment by suitman87 on Mar 21, 2017 2:58am
He also wanted a healthcare system similar to universal healthcare, and that certainly wasn't the care. Republicans love vouchers. if they ever try any sort of liberal policy they often just practice it by giving vouchers rather than forcing the companies to follow a specific set of business killing rules. i am a pretty liberal person, but i understand republicans, why kill an industry when ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities